1010 related articles for article (PubMed ID: 15224025)
21. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
[TBL] [Abstract][Full Text] [Related]
22. Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery.
Ballotta A; Saleh HZ; El Baghdady HW; Gomaa M; Belloli F; Kandil H; Balbaa Y; Bettini F; Bossone E; Menicanti L; Frigiola A; Bellucci C; Mehta RH
J Thorac Cardiovasc Surg; 2007 Jul; 134(1):132-8. PubMed ID: 17599498
[TBL] [Abstract][Full Text] [Related]
23. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
24. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting.
Puskas JD; Williams WH; Duke PG; Staples JR; Glas KE; Marshall JJ; Leimbach M; Huber P; Garas S; Sammons BH; McCall SA; Petersen RJ; Bailey DE; Chu H; Mahoney EM; Weintraub WS; Guyton RA
J Thorac Cardiovasc Surg; 2003 Apr; 125(4):797-808. PubMed ID: 12698142
[TBL] [Abstract][Full Text] [Related]
25. The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial.
Greilich PE; Jessen ME; Satyanarayana N; Whitten CW; Nuttall GA; Beckham JM; Wall MH; Butterworth JF
Anesth Analg; 2009 Jul; 109(1):15-24. PubMed ID: 19535691
[TBL] [Abstract][Full Text] [Related]
26. Activation of the coagulation system during coronary artery bypass grafting: comparison between on-pump and off-pump techniques.
Paparella D; Galeone A; Venneri MT; Coviello M; Scrascia G; Marraudino N; Quaranta M; de Luca Tupputi Schinosa L; Brister SJ
J Thorac Cardiovasc Surg; 2006 Feb; 131(2):290-7. PubMed ID: 16434256
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
Elwatidy S; Jamjoom Z; Elgamal E; Zakaria A; Turkistani A; El-Dawlatly A
Spine (Phila Pa 1976); 2008 Nov; 33(24):2577-80. PubMed ID: 19011538
[TBL] [Abstract][Full Text] [Related]
28. Tranexamic Acid in on-pump coronary artery bypass grafting without clopidogrel and aspirin cessation: randomized trial and 1-year follow-up.
Shi J; Wang G; Lv H; Yuan S; Wang Y; Ji H; Li L
Ann Thorac Surg; 2013 Mar; 95(3):795-802. PubMed ID: 22959576
[TBL] [Abstract][Full Text] [Related]
29. A differential release of matrix metalloproteinases 9 and 2 during coronary artery bypass grafting and off-pump coronary artery bypass surgery.
Sokal A; Zembala M; Radomski A; Kocher A; Pacholewicz J; Los J; Jedrzejczyk E; Zembala M; Radomski M
J Thorac Cardiovasc Surg; 2009 May; 137(5):1218-24. PubMed ID: 19379995
[TBL] [Abstract][Full Text] [Related]
30. Surgical volume and outcomes of off-pump coronary artery bypass graft surgery: Does it matter?
Konety SH; Rosenthal GE; Vaughan-Sarrazin MS
J Thorac Cardiovasc Surg; 2009 May; 137(5):1116-23.e1. PubMed ID: 19379976
[TBL] [Abstract][Full Text] [Related]
31. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
[TBL] [Abstract][Full Text] [Related]
32. Intravenous tranexamic acid use in myomectomy: a prospective randomized double-blind placebo controlled study.
Caglar GS; Tasci Y; Kayikcioglu F; Haberal A
Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):227-31. PubMed ID: 17499419
[TBL] [Abstract][Full Text] [Related]
33. Early and long-term outcomes in the elderly: comparison between off-pump and on-pump techniques in 1191 patients undergoing coronary artery bypass grafting.
Li Y; Zheng Z; Hu S
J Thorac Cardiovasc Surg; 2008 Sep; 136(3):657-64. PubMed ID: 18805269
[TBL] [Abstract][Full Text] [Related]
34. Tranexamic acid as a means of reducing the need for blood and blood component therapy in children undergoing open heart surgery for congenital cyanotic heart disease.
Vacharaksa K; Prakanrattana U; Suksompong S; Chumpathong S
J Med Assoc Thai; 2002 Sep; 85 Suppl 3():S904-9. PubMed ID: 12452228
[TBL] [Abstract][Full Text] [Related]
35. Tranexamic acid reduces bleeding after off-pump coronary artery bypass grafting.
Jares M; Vanek T; Straka Z; Brucek P
J Cardiovasc Surg (Torino); 2003 Apr; 44(2):205-8. PubMed ID: 12813384
[TBL] [Abstract][Full Text] [Related]
36. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
[TBL] [Abstract][Full Text] [Related]
37. Tranexamic acid in off-pump coronary surgery: a preliminary, randomized, double-blind, placebo-controlled study.
Casati V; Gerli C; Franco A; Torri G; D'Angelo A; Benussi S; Alfieri O
Ann Thorac Surg; 2001 Aug; 72(2):470-5. PubMed ID: 11515884
[TBL] [Abstract][Full Text] [Related]
38. Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass.
Dial S; Delabays E; Albert M; Gonzalez A; Camarda J; Law A; Menzies D
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):654-61. PubMed ID: 16153909
[TBL] [Abstract][Full Text] [Related]
39. Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery.
Shim JK; Choi YS; Oh YJ; Bang SO; Yoo KJ; Kwak YL
J Thorac Cardiovasc Surg; 2007 Jul; 134(1):59-64. PubMed ID: 17599487
[TBL] [Abstract][Full Text] [Related]
40. Hetastarch increases the risk of bleeding complications in patients after off-pump coronary bypass surgery: a randomized clinical trial.
Hecht-Dolnik M; Barkan H; Taharka A; Loftus J
J Thorac Cardiovasc Surg; 2009 Sep; 138(3):703-11. PubMed ID: 19698859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
